While Medtronic has struggled to keep up with the broader market over the past year, analysts remain fairly upbeat on its ...

Although the company's advancements have influenced contemporary healthcare, its stock presents a more cautious narrative ...

Medical device specialist Medtronic (NYSE: MDT) has not been the best of investments over the past five years. The stock has ...

MDT's CRBN stock provides excellent ergonomics and weighs less than 30 ounces. This year MDT, known for their many precision ...

Medtronic announced a spin-off of its diabetes business in May, which will be completed in 2026. Read more on MDT stock here.

Tandem (TNDM) stock falls and Insulet (PODD) stock gains as investors react to the companies' Q2 2025 results and guidance.

Medtronic also disclosed severance for a former SVP, and pay for its median employee, and a slight decrease in global ...

Orchestra BioMed reported that it has secured over $111 million in financing through a series of transactions and ...

CommScope (COMM) Rides on Strong Demand, Strategic Divestiture Per the Zacks analyst, healthy traction in the cloud and data ...

Orchestra BioMed announced today that it completed strategic transactions and equity offerings worth an expected $111.2 ...

The proposal would introduce competitive bidding for insulin pumps and change how Medicare pays for durable medical equipment ...

Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to a loss of $0.37 per share a year ago. These ...